特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
953093

ペプチドによるがん治療薬市場 - 市場シェア、規模、動向、業界分析:2020年~2027年

Peptide Based Cancer Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Type ; By Cancer Type ; By Mode of Mechanism, By Distribution Channel, By Regions; Segment Forecast, 2020 -2027

出版日: | 発行: Polaris Market Research | ページ情報: 英文 113 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.59円
ペプチドによるがん治療薬市場 - 市場シェア、規模、動向、業界分析:2020年~2027年
出版日: 2020年07月01日
発行: Polaris Market Research
ページ情報: 英文 113 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のペプチドによるがん治療薬市場規模は、2027年まで171億8000万米ドルに達すると予測されています。ペプチドは、アミノ酸モノマーの天然または人工の生物学的結合によって作成される化合物です。ペプチドは、がんなどのいくつかの病気を治療するための治療法で広く使用されています。

当レポートでは、世界のペプチドによるがん治療薬市場について調査分析し、市場概要、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 ペプチドによるがん治療薬市場の考察

  • ペプチドによるがん治療薬:業界スナップショット
  • ペプチドによるがん治療薬市場力学
  • ポーターのファイブフォース分析
  • PESTLE分析
  • ペプチドによるがん治療薬市場の業界動向

第5章 ペプチドによるがん治療薬市場の評価:薬剤の種類別

  • 主な調査結果
  • イントロダクション
  • ゴセレリン
  • ボルテゾミブ
  • リュープロレリン
  • その他

第6章 ペプチドによるがん治療薬市場の評価:がんの種類別

  • 主な調査結果
  • イントロダクション
  • 肺がん
  • 乳がん
  • 大腸がん
  • 前立腺がん
  • 皮膚ガン
  • 胃がん

第7章 ペプチドによるがん治療薬市場の評価:作用機序別

  • 主な調査結果
  • イントロダクション
  • 抑制
  • 壊死の誘発
  • プロアポトーシスペプチド

第8章 ペプチドによるがん治療薬市場の評価:流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 ペプチドによるがん治療薬市場の評価:地域別

  • 主な調査結果
  • イントロダクション
  • ペプチドによるがん治療薬市場の評価:地域別
  • ペプチドによるがん治療薬市場:北米
  • ペプチドによるがん治療薬市場:欧州
  • ペプチドによるがん治療薬市場:アジア太平洋
  • ペプチドによるがん治療薬市場:中東・アフリカ
  • ペプチドによるがん治療薬市場:ラテンアメリカ

第10章 競合情勢

第11章 企業プロファイル

  • AstraZeneca PLC
  • Abbott
  • Allergan plc
  • Teva Pharmaceuticals
  • Pfizer Inc.
  • Takeda Pharmaceutical
  • Amgen, Inc.
  • Johnson & Johnson
  • AbbVie Inc.
  • Valeant Pharmaceuticals Inc.
図表

List of Tables

  • Table 1 Global Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 2 Global Peptide Based Cancer Therapeutics Market, by Cancer Type , by Region, 2016 - 2027 (USD Million)
  • Table 3 Global Peptide Based Cancer Therapeutics Market, by Mode of Mechanism , by Region, 2016 - 2027 (USD Million)
  • Table 4 Global Peptide Based Cancer Therapeutics Market, by Distribution Channel, by Region, 2016 - 2027 (USD Million)
  • Table 5 Peptide Based Cancer Therapeutics Market Assessment, By Geography, 2016 - 2027 (USD Million)
  • Table 6 North America: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 7 North America: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 8 North America: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 9 North America: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 10 U.S.: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 11 U.S.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 12 U.S.: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 13 U.S.: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 14 Canada: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 15 Canada: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 16 Canada: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 17 Canada: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 18 Europe: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 19 Europe: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 20 Europe: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 21 Europe: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 22 UK: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 23 UK: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 24 UK: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 25 UK: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 26 France: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 27 France: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 28 France: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 29 France: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 30 Germany: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 31 Germany: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 32 Germany: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 33 Germany: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 34 Italy: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 35 Italy: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 36 Italy: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 37 Italy: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 38 Netherlands: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 39 Netherlands: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 40 Netherlands: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 41 Netherlands: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 42 Austria: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 43 Austria: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 44 Austria: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 45 Austria: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 46 Asia Pacific: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 47 Asia Pacific: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 48 Asia Pacific: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 49 Asia Pacific: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 50 China: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 51 China: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 52 China: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 53 China: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 54 India: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 55 India: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 56 India: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 57 India: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 58 Japan: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 59 Japan: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 60 Japan: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 61 Japan: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 62 Malaysia: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 63 Malaysia: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 64 Malaysia: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 65 Malaysia: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 66 Indonesia: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 67 Indonesia: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 68 Indonesia: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 69 Indonesia: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 70 South Korea: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 71 South Korea: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 72 South Korea: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 73 South Korea: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 74 Middle East & Africa: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 75 Middle East & Africa: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 76 Middle East & Africa: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 77 Middle East & Africa: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 78 Saudi Arabia: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 79 Saudi Arabia: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 80 Saudi Arabia: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 81 Saudi Arabia: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 82 Israel: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 83 Israel: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 84 Israel: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 85 Israel: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 86 South Africa: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 87 South Africa: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 88 South Africa: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 89 South Africa: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 90 Latin America: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 91 Latin America: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 92 Latin America: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 93 Latin America: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 94 Brazil: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 95 Brazil: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 96 Brazil: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 97 Brazil: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 98 Mexico: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 99 Mexico: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 100 Mexico: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 101 Mexico: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 102 Argentina: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 103 Argentina: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • Table 104 Argentina: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • Table 105 Argentina: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)

List of Figures

  • Figure 1. Market Highlights (2019, Revenue)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top Down & Bottom Up Approach
  • Figure 4. Market by Geography
  • Figure 6. Porter's Five Forces
  • Figure 7. Market by Drug Type
  • Figure 8. Global Peptide Based Cancer Therapeutics Market, By Drug Type, 2019 & 2027 (USD Million)
  • Figure 9. Market by Cancer Type
  • Figure 8. Global Peptide Based Cancer Therapeutics Market, By Cancer Type, 2019 & 2027 (USD Million)
  • Figure 9. Market by Mode of Mechanism
  • Figure 10. Global Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2019 & 2027 (USD Million)
  • Figure 11. Market by Distribution Channel
  • Figure 12. Global Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2019 & 2027 (USD Million)
  • Figure 13. Peptide Based Cancer Therapeutics Market Assessment, By Geography, 2016- 2027 (USD Million)
  • Figure 14. Strategic Analysis - Peptide Based Cancer Therapeutics Market
目次
Product Code: PM1696

Title:
Peptide Based Cancer Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Goserelin, Bortezomib, Leuprorelin, and Others); By Cancer Type (Lung, Breast, Colorectal, Prostrate, Skin, and Stomach Cancer); By Mode of Mechanism (Inhibitory, Necrosis Inducing, and Pro-Apoptotic Peptides), By Distribution Channel (Hospital, Retail, and Online Pharmacies), By Regions; Segment Forecast, 2020 -2027.

The global peptide based cancer therapeutics market size is expected to reach USD 17.18 billion by 2027 according to a new study by Polaris Market Research. The report "Peptide Based Cancer Therapeutics Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Goserelin, Bortezomib, Leuprorelin, and Others); By Cancer Type (Lung, Breast, Colorectal, Prostrate, Skin, and Stomach Cancer); By Mode of Mechanism (Inhibitory, Necrosis Inducing, and Pro-Apoptotic Peptides), By Distribution Channel (Hospital, Retail, and Online Pharmacies), By Regions; Segment Forecast, 2020 -2027" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Peptides are compounds that are created by natural or artificial biological linking of amino acid monomers. Peptides are being widely used in therapeutics to treat several ailments, including cancer owing to their precision based nature, targeting solid tumor cells in the body. Peptide based cancer therapeutics have shown effective results against cancer as opposed to conventional cancer treatments, without much side effects.

Peptide based therapies in the treatment of cancer are majorly classified as pure play peptide therapy, vaccines based on peptide, and peptide conjugate nanomaterials. These therapies possess several advantages over others such as easy administration, specificity in targeting tumor tissues, fewer side effects as compared to drugs, and low cost of peptides.

The factors propelling the market growth are the increasing prevalence of cancer across the world, cancer screening programs in emerging countries, and the high specificity of peptide based cancer vaccines. In 2016, according to analysis by NCA (National Cancer Center), 1,010,200 cancer cases were recorded, with 576,100 male patients and 434,100 women cases. The mortality rate in 2016 recorded a high with more than 374,000 cancer deaths in the country, particularly deaths associated with the most common colorectal cancer followed by gastric, lung, prostrate and breast cancers.

Market participants such as AstraZeneca PLC, Abbott, Allergan plc, Teva Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical, Amgen, Inc., Johnson & Johnson, AbbVie Inc., and Valeant Pharmaceuticals Inc., are some of the key players operating in the concerned market. In January 2020, Sony Brook University (SBU) extended its funding on FABP5 inhibitors to 2025 by demonstrating novel approach to treat last stage prostate cancer. According to the researchers of the SBU specific fatty acid binding protein (FABP) may be help in stopping cancer.

In June 2017, AstraZeneca along with National Cancer Institute Eleven entered into cooperative research and development agreement with Eleven Biotherapeutics to develop Vicinium in combination with AstraZeneca's immune checkpoint inhibitor, Imfinzi to treat non-muscle invasive bladder cancer.

Polaris Market research has segmented the peptide based cancer therapeutics market report on the basis of drug type, cancer type, mode of mechanism, distribution channel, and region

Peptide Based Cancer Therapeutics Drug Type Outlook (Revenue - USD Million, 2016 - 2027)

  • Goserelin
  • Bortezomib
  • Leuprorelin
  • Others

Peptide Based Cancer Therapeutic Cancer Type Outlook (Revenue - USD Million, 2016 - 2027)

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Skin Cancer
  • Stomach Cancer

Peptide Based Cancer Therapeutics Mode of Action Outlook (Revenue - USD Million, 2016 - 2027)

  • Inhibitory
  • Necrosis Inducing
  • Pro-Apoptotic Peptides

Peptide Based Cancer Therapeutics Distribution Channel Outlook (Revenue - USD Million, 2016 - 2027)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Peptide Based Cancer Therapeutics Regional Outlook (Revenue - USD Million, 2016 - 2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Netherlands
    • Austria
  • Asia Pacific
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Indonesia
  • Central & South America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Table of Contents

1.Introduction

  • 1.1.Report Description
    • 1.1.1.Objectives of the Study
    • 1.1.2.Market Scope
    • 1.1.3.Assumptions
  • 1.2.Stakeholders

2.Executive Summary

  • 2.1.Market Highlights

3.Research Methodology

  • 3.1.Overview
    • 3.1.1.Data Mining
  • 3.2.Data Sources
    • 3.2.1.Primary Sources
    • 3.2.2.Secondary Sources

4.Peptide Based Cancer Therapeutics Market Insights

  • 4.1.Peptide Based Cancer Therapeutics - Industry snapshot
  • 4.2.Peptide Based Cancer Therapeutics Market Dynamics
    • 4.2.1.Drivers and Opportunities
      • 4.2.1.1.Rising cases of cancer
      • 4.2.1.2.Research and innovation in the concerned field
    • 4.2.2.Restraints and Challenges
      • 4.2.2.1.Side effects associated of drugs
  • 4.3.Porter's Five Forces Analysis
    • 4.3.1.Bargaining Power of Suppliers (Moderate)
    • 4.3.2.Threats of New Entrants: (Low)
    • 4.3.3.Bargaining Power of Buyers (Moderate)
    • 4.3.4.Threat of Substitute (Moderate)
    • 4.3.5.Rivalry among existing firms (High)
  • 4.4.PESTLE Analysis
  • 4.5.Peptide Based Cancer Therapeutics Market Industry trends

5.Peptide Based Cancer Therapeutics Market Assessment by Drug Type

  • 5.1.Key Findings
  • 5.2.Introduction
    • 5.2.1.Global Peptide Based Cancer Therapeutics Market, By Drug Type, 2016 - 2027 (USD Million)
  • 5.3.Goserelin
    • 5.3.1.Global Peptide Based Cancer Therapeutics Market, by Goserelin, by Region, 2016- 2027 (USD Million)
  • 5.4.Bortezomib
    • 5.4.1.Global Peptide Based Cancer Therapeutics Market, by Bortezomib, by Region, 2016- 2027 (USD Million)
  • 5.5.Leuprorelin
    • 5.5.1.Global Peptide Based Cancer Therapeutics Market, by Leuprorelin, by Region, 2016- 2027 (USD Million)
  • 5.6.Others
    • 5.6.1.Global Peptide Based Cancer Therapeutics Market, by Others, by Region, 2016- 2027 (USD Million)

6.Global Peptide Based Cancer Therapeutics Market, by Cancer Type

  • 6.1.Key Findings
  • 6.2.Introduction
    • 6.2.1.Global Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016 - 2027 (USD Million)
  • 6.3.Lung Cancer
    • 6.3.1.Global Peptide Based Cancer Therapeutics Market, by Lung Cancer, By Region, 2016- 2027 (USD Million)
  • 6.4.Breast Cancer
    • 6.4.1.Global Peptide Based Cancer Therapeutics Market, by Breast Cancer, by Region, 2016- 2027 (USD Million)
  • 6.5.Colorectal Cancer
    • 6.5.1.Global Peptide Based Cancer Therapeutics Market, by Colorectal Cancer, by Region, 2016- 2027 (USD Million)
  • 6.6.Prostrate Cancer
    • 6.6.1.Global Peptide Based Cancer Therapeutics Market, by Prostrate Cancer, by Region, 2016- 2027 (USD Million)
  • 6.7.Skin Cancer
    • 6.7.1.Global Peptide Based Cancer Therapeutics Market, by Skin Cancer, by Region, 2016- 2027 (USD Million)
  • 6.8.Stomach Cancer
    • 6.8.1.Global Peptide Based Cancer Therapeutics Market, by Stomach Cancer, by Region, 2016- 2027 (USD Million)

7.Global Peptide Based Cancer Therapeutics Market, by Mode of Mechanism

  • 7.1.Key Findings
  • 7.2.Introduction
    • 7.2.1.Global Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
  • 7.3.Inhibitory
    • 7.3.1.Global Peptide Based Cancer Therapeutics Market, by Inhibitory, By Region, 2016- 2027 (USD Million)
  • 7.4.Necrosis Inducing
    • 7.4.1.Global Peptide Based Cancer Therapeutics Market, by Necrosis Inducing, by Region, 2016- 2027 (USD Million)
  • 7.5.Pro-Apoptotic Peptides
    • 7.5.1.Global Peptide Based Cancer Therapeutics Market, by Pro-Apoptotic Peptides, by Region, 2016- 2027 (USD Million)

8.Peptide Based Cancer Therapeutics Market Assessment by Distribution Channel

  • 8.1.Key Findings
  • 8.2.Introduction
    • 8.2.1.Global Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 8.3.Hospital Pharmacies
    • 8.3.1.Global Peptide Based Cancer Therapeutics Market, by Hospital Pharmacies, by Region, 2016- 2027 (USD Million)
  • 8.4.Retail Pharmacies
    • 8.4.1.Global Peptide Based Cancer Therapeutics Market, by Retail Pharmacies, by Region, 2016- 2027 (USD Million)
  • 8.5.Online Pharmacies
    • 8.5.1.Global Peptide Based Cancer Therapeutics Market, by Online Pharmacies, by Region, 2016- 2027 (USD Million)

9.Peptide Based Cancer Therapeutics Market Assessment by Geography

  • 9.1.Key findings
  • 9.2.Introduction
    • 9.2.1.Peptide Based Cancer Therapeutics Market Assessment, By Geography, 2016- 2027 (USD Million)
  • 9.3.Peptide Based Cancer Therapeutics Market - North America
    • 9.3.1.North America: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
    • 9.3.2.North America: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
    • 9.3.3.North America: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016 - 2027 (USD Million)
    • 9.3.4.North America: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.3.5.Peptide Based Cancer Therapeutics Market - U.S.
      • 9.3.5.1.U.S.: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.3.5.2.U.S.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.3.5.3.U.S.: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.3.5.4.U.S.: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.3.6.Peptide Based Cancer Therapeutics Market - Canada
      • 9.3.6.1.Canada: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.3.6.2.Canada.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.3.6.3.Canada: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.3.6.4.Canada: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
  • 9.4.Peptide Based Cancer Therapeutics Market - Europe
    • 9.4.1.Europe: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
    • 9.4.2.Europe.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
    • 9.4.3.Europe: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
    • 9.4.4.Europe: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.4.5.Peptide Based Cancer Therapeutics Market - UK
      • 9.4.5.1.UK: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.4.5.2.UK.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.4.5.3.UK: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.4.5.4.UK: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.4.6.Peptide Based Cancer Therapeutics Market - France
      • 9.4.6.1.France: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.4.6.2.France.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.4.6.3.France: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.4.6.4.France: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.4.7.Peptide Based Cancer Therapeutics Market - Germany
      • 9.4.7.1.Germany: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.4.7.2.Germany.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.4.7.3.Germany: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.4.7.4.Germany: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.4.8.Peptide Based Cancer Therapeutics Market - Italy
      • 9.4.8.1.Italy: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.4.8.2.Italy.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.4.8.3.Italy: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.4.8.4.Italy: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.4.9.Peptide Based Cancer Therapeutics Market - Spain
      • 9.4.9.1.Spain: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.4.9.2.Spain.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.4.9.3.Spain: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.4.9.4.Spain: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.4.10.Peptide Based Cancer Therapeutics Market - Netherlands
      • 9.4.10.1.Netherlands: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.4.10.2.Netherlands.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.4.10.3.Netherlands: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.4.10.4.Netherlands: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.4.11.Peptide Based Cancer Therapeutics Market - Austria
      • 9.4.11.1.Austria: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.4.11.2.Austria.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.4.11.3.Austria: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.4.11.4.Austria: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
  • 9.5.Peptide Based Cancer Therapeutics Market - Asia-Pacific
    • 9.5.1.Asia Pacific: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
    • 9.5.2.Asia Pacific.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
    • 9.5.3.Asia-pacific: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
    • 9.5.4.Asia-pacific: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.5.5.Peptide Based Cancer Therapeutics Market - China
      • 9.5.5.1.China: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.5.5.2.China.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.5.5.3.China: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.5.5.4.China: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.5.6.Peptide Based Cancer Therapeutics Market - India
      • 9.5.6.1.India: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.5.6.2.India.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.5.6.3.India: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.5.6.4.India: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.5.7.Peptide Based Cancer Therapeutics Market - Malaysia
      • 9.5.7.1.Malaysia: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.5.7.2.Malaysia.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.5.7.3.Malaysia: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.5.7.4.Malaysia: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.5.8.Peptide Based Cancer Therapeutics Market - Japan
      • 9.5.8.1.Japan: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.5.8.2.Japan.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.5.8.3.Japan: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.5.8.4.Japan: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.5.9.Peptide Based Cancer Therapeutics Market - Indonesia
      • 9.5.9.1.Indonesia: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.5.9.2.Indonesia.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.5.9.3.Indonesia: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.5.9.4.Indonesia: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.5.10.Peptide Based Cancer Therapeutics Market - South Korea
      • 9.5.10.1.South Korea: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.5.10.2.South Korea.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.5.10.3.South Korea: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.5.10.4.South Korea: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
  • 9.6.Peptide Based Cancer Therapeutics Market - Middle East & Africa
    • 9.6.1.Middle East & Africa: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
    • 9.6.2.Middle East & Africa.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
    • 9.6.3.Middle East & Africa: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
    • 9.6.4.Middle East & Africa: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.6.5.Peptide Based Cancer Therapeutics Market - Saudi Arabia
      • 9.6.5.1.Saudi Arabia: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.6.5.2.Saudi Arabia.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.6.5.3.Saudi Arabia: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.6.5.4.Saudi Arabia: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.6.6.Peptide Based Cancer Therapeutics Market - UAE
      • 9.6.6.1.UAE: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.6.6.2.UAE.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.6.6.3.UAE: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.6.6.4.UAE: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.6.7.Peptide Based Cancer Therapeutics Market - Israel
      • 9.6.7.1.Israel: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.6.7.2.Israel.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.6.7.3.Israel: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.6.7.4.Israel: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.6.8.Peptide Based Cancer Therapeutics Market - South Africa
      • 9.6.8.1.South Africa: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.6.8.2.South Africa.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.6.8.3.South Africa: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.6.8.4.South Africa: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
  • 9.7.Peptide Based Cancer Therapeutics Market - Latin America
    • 9.7.1.Latin America: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
    • 9.7.2.Latin America.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
    • 9.7.3.Latin America: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
    • 9.7.4.Latin America: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.7.5.Peptide Based Cancer Therapeutics Market - Mexico
      • 9.7.5.1.Mexico: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.7.5.2.Mexico.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.7.5.3.Mexico: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.7.5.4.Mexico: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.7.6.Peptide Based Cancer Therapeutics Market - Brazil
      • 9.7.6.1.Brazil: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.7.6.2.Brazil.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.7.6.3.Brazil: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.7.6.4.Brazil: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)
    • 9.7.7.Peptide Based Cancer Therapeutics Market - Argentina
      • 9.7.7.1.Argentina: Peptide Based Cancer Therapeutics Market, By Drug Type, 2016- 2027 (USD Million)
      • 9.7.7.2.Argentina.: Peptide Based Cancer Therapeutics Market, By Cancer Type, 2016- 2027 (USD Million)
      • 9.7.7.3.Argentina: Peptide Based Cancer Therapeutics Market, By Mode of Mechanism, 2016- 2027 (USD Million)
      • 9.7.7.4.Argentina: Peptide Based Cancer Therapeutics Market, By Distribution Channel, 2016- 2027 (USD Million)

10.Competitive Landscape

  • 10.1.Expansion and Acquisition Analysis
    • 10.1.1.Expansion
    • 10.1.2.Acquisitions
  • 10.2.Partnerships/Collaborations/Agreements/Exhibitions

11.Company Profiles

  • 11.1.AstraZeneca PLC
    • 11.1.1.Company Overview
    • 11.1.2.Financials
    • 11.1.3.Product Benchmarking
    • 11.1.4.Recent Development
  • 11.2.Abbott
    • 11.2.1.Company Overview
    • 11.2.2.Financials
    • 11.2.3.Product Benchmarking
    • 11.2.4.Recent Development
  • 11.3.Allergan plc
    • 11.3.1.Company Overview
    • 11.3.2.Financials
    • 11.3.3.Product Benchmarking
    • 11.3.4.Recent Development
  • 11.4.Teva Pharmaceuticals
    • 11.4.1.Company Overview
    • 11.4.2.Financials
    • 11.4.3.Product Benchmarking
    • 11.4.4.Recent Development
  • 11.5.Pfizer Inc.
    • 11.5.1.Company Overview
    • 11.5.2.Financials
    • 11.5.3.Product Benchmarking
    • 11.5.4.Recent Development
  • 11.6.Takeda Pharmaceutical
    • 11.6.1.Company Overview
    • 11.6.2.Financials
    • 11.6.3.Product Benchmarking
    • 11.6.4.Recent Development
  • 11.7.Amgen, Inc.
    • 11.7.1.Company Overview
    • 11.7.2.Financials
    • 11.7.3.Product Benchmarking
    • 11.7.4.Recent Development
  • 11.8.Johnson & Johnson
    • 11.8.1.Company Overview
    • 11.8.2.Financials
    • 11.8.3.Product Benchmarking
    • 11.8.4.Recent Development
  • 11.9.AbbVie Inc.
    • 11.9.1.Company Overview
    • 11.9.2.Financials
    • 11.9.3.Product Benchmarking
    • 11.9.4.Recent Development
  • 11.10.Valeant Pharmaceuticals Inc.
    • 11.10.1.Company Overview
    • 11.10.2.Financials
    • 11.10.3.Product Benchmarking
    • 11.10.4.Recent Development
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.